Connect with us

Health

Volunteers praised for huge role in giving UK public Covid jabs | Coronavirus

Published

on

Tens of thousands of vaccine volunteers have been praised for giving up about two million hours of their time to help with the rollout of Covid jabs throughout 2021.

A woman who translated crucial health messages into Punjabi to reach more communities is among more than 100,000 people who donated their time to the vaccine effort in the past year.

More than 132m coronavirus jabs were given last year in the largest vaccine campaign in British history. More than 90% of people in the UK over the age of 12 have now had their first dose of a Covid-19 jab and 82.4% have had their second.

After the emergence of the Omicron variant triggered an acceleration of the rollout over the festive season, more than 1.6 million people received their booster dose in the final week of 2021, bringing the total number of boosted adults in the UK to nearly 34 million, including three in four eligible adults in England.

NHS England said volunteers working alongside healthcare staff had particularly helped during the ramped-up supply of jabs and boosters in December.

The health service launched a recruitment drive to speed up the distribution of jabs and so far 17,500 people have registered their interest in paid vaccination roles, NHS England said.

uk corona cases

A further 48,000 people have registered as steward volunteers through the NHS Volunteer Responders programme in just over a month, of which more than 10,000 have already deployed.

Working alongside the NHS, St John Ambulance has seen 17,000 people come forward to do shifts as volunteer vaccinators.

The health secretary, Sajid Javid, said the success of the vaccination programme was “astounding and a true reflection of the fantastic work of our NHS and its volunteers. I want to thank each and every one of them”.

NHS England’s chief executive, Amanda Pritchard, said the efforts of volunteers would “undoubtedly help to save many more lives”.

She said: “Alongside NHS staff, our selfless volunteers have worked tirelessly to protect the nation – in football stadiums, shopping centres, Christmas markets and countless other vaccination sites up and down the country.

“I want to give my personal thanks to everyone who has given up their time to help us beat record after record – continuing to make the NHS Covid-19 vaccination programme the biggest and most successful in health service history.”

Boris Johnson set the target of offering all eligible adults the chance to get their booster jabs by the end of January, but after the emergence of Omicron he brought forward the deadline to the new year.

Millions of people queued at about 3,000 vaccination centres, and on 18 December NHS England administered a record 830,000 jabs in a single day.

Jaz Kaur Bangerh, from Leeds, has been promoting messages about the safety and effectiveness of the vaccine in ethnic minority communities, including translating information into Punjabi.

“Volunteering for the vaccination programme, I have helped people to fill in forms, guided them to the right place and answered any questions, especially if they were a bit anxious in the early days, when there was a lot of information out there.”

John Hardman, who has volunteered at jab sites in the capital including Wembley stadium and the Science Museum, said he “can’t recommend it [volunteering] enough”.

“There are lots of opportunities to support locally, even if just for a few sessions.”

NHS England said people interested in getting involved can search NHS vaccine team online.

Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.

Health

Solar storms may cause up to 5500 heart-related deaths in a given year

Published

on

In an approximate 11-year cycle, the sun blasts out charged particles and magnetised plasma that can distort Earth’s magnetic field, which may disrupt our body clock and ultimately affect our heart



Health



17 June 2022

A solar storm

Jurik Peter/Shutterstock

Solar storms that disrupt Earth’s magnetic field may cause up to 5500 heart-related deaths in the US in a given year.

The sun goes through cycles of high and low activity that repeat approximately every 11 years. During periods of high activity, it blasts out charged particles and magnetised plasma that can distort Earth’s magnetic field.

These so-called solar storms can cause glitches in our power grids and bring down Earth-orbiting satellites. A handful of studies have also hinted that they increase the risk of …

Source link

Continue Reading

Health

UK Covid infection rate rising, with more than a million cases in England | Coronavirus

Published

on

Coronavirus infections are rising in the UK, figures have revealed, with experts noting the increase is probably down to the more transmissible BA.4 and BA.5 Omicron variants.

The figures from the Office for National Statistics (ONS), based on swabs collected from randomly selected households, reveal that in the week ending 11 June an estimated one in 50 people in the community in England are thought to have had Covid – around 1.13 million people.

The figure is even higher, at one in 45, in both Wales and Northern Ireland, while it was highest in Scotland where, in the week ending 10 June, one in 30 people are thought to have been infected.

While the figures remain below the peak levels of infection seen earlier this year, when around one in 13 people in England had Covid, the findings are a rise on the previous week where one in 70 people in England were thought to be infected. Furthermore, the data reveals increases in all regions of England, except the north-east, and across all age groups.

Experts say that a key factor in the increase is probably the rise of the Covid variants of concern BA.4 and BA.5.

“Infections have increased across all four UK nations, driven by rising numbers of people infected with the BA.4 and BA.5 Omicron variants,” said Kara Steel, senior statistician for the Covid-19 Infection Survey.

While Steel said it remained too early to say if this was the start of another wave, others have warned it may already have begun, with increased mixing and travelling among other factors fuelling a rise in cases.

Among concerns scientists have raised are that BA.4, BA.5 and another variant on the rise, BA.2.12.1, replicate more efficiently in human lung cells than BA.2.

Prof Azra Ghani, an epidemiologist at Imperial College London, said the latest figures were not surprising, and might rise further.

“This increase in infection prevalence is likely due to the growth of the BA.4 and BA.5 Omicron subvariants, which as we have seen elsewhere in Europe, appear to be able to escape immunity generated from previous Omicron subvariants,” she said.

“It is therefore possible that we will continue to see some growth in infection prevalence in the coming weeks and consequently an increase in hospitalisations, although these subvariants do not currently appear to result in any significantly changed severity profile. This does however serve as a reminder that the Covid-19 pandemic is not over.”

Source link

Continue Reading

Health

NHS to offer women in England drug that cuts recurrence of breast cancer | Breast cancer

Published

on

Thousands of women in England with breast cancer are to benefit from a new pill on the NHS which reduces the risk of the disease coming back.

The National Institute for Health and Care Excellence (Nice) has given the green light to abemaciclib, which cuts the chance of breast cancer returning after a patient has had surgery to remove a tumour.

Trials showed that patients who had the drug with hormone therapy had a more than 30% improved chance of their cancer not coming back after surgery, compared with hormone therapy alone.

“It’s fantastic thousands of women with this type of primary breast cancer will now have an additional treatment option available on the NHS to help further reduce the risk of the disease coming back,” said Delyth Morgan, the chief executive of charity Breast Cancer Now.

“The fear of breast cancer returning or spreading to other parts of their body and becoming incurable can cause considerable anxiety for so many women and their loved ones.

“New effective treatments such as abemaciclib, which can offer more women the chance to further reduce the risk of the disease recurring, are therefore extremely welcome and this is an important step change in the drug options available for this group of patients.”

The twice-a-day pill is suitable for women with hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence who have had surgery. About 4,000 women will benefit initially, Nice said.

Helen Knight, the interim director of medicines evaluation at Nice, said the draft recommendation came less than a month after abemaciclib received its licence.

“The fact that we have been able to produce draft recommendations so quickly is testament to the success of our ambition to support patient access to clinically and cost effective treatments as early as possible,” said Knight. “Until now there have been no targeted treatments for people with this type of breast cancer.

“Abemaciclib with hormone therapy represents a significant improvement in how it is treated because being able to have a targeted treatment earlier after surgery will increase the chance of curing the disease and reduce the likelihood of developing incurable advanced disease.”

Abemaciclib works by targeting and inhibiting proteins in cancer cells which allow the cancer to divide and grow. It normally costs £2,950 for a packet of 56 150mg-tablets, but the manufacturer, Eli Lilly, has agreed an undisclosed discounted price for NHS England.

“Thanks in part to this latest deal struck by NHS England, NHS patients will be able to access another new targeted drug for a common and aggressive form of breast cancer,” said Prof Peter Johnson, the cancer director of NHS England.

“Abemaciclib, when used alongside a hormone therapy, offers a new, doubly targeted, treatment option, helping to increase the chances of beating the cancer for good, as well as meeting the NHS’s commitment to delivering improved cancer care under our long-term plan.”

Source link

Continue Reading

Trending